Platelet Activation
Concept
Vocabulary Service
Overview
subject area of
-
A Significant Portion of the Aequorin Luminescent Signal from Stimulated Human and Rabbit Platelets is Due to Exposure of the Aequorin to Calcium in the Suspending Medium Academic Article
-
A comparative study of platelet factor 4‐enhanced platelet activation assays for the diagnosis of heparin‐induced thrombocytopenia Academic Article
-
A single dose of aprotinin prevents platelet hyporeactivity after coronary artery bypass graft surgery Academic Article
-
A trypsin-like platelet protease propagates protease-activated receptor-1 cleavage and platelet activation Academic Article
-
Activated platelets form protected zones of adhesion on fibrinogen and fibronectin-coated surfaces. Academic Article
-
Activation of platelets by sera containing igg1 heparin-dependent antibodies: an explanation for the predominance of the Fcγrlla “low responder” (his131) gene in patients with heparin-induced thrombocytopenia Academic Article
-
Acute coronary syndromes: a focus on thrombin. Academic Article
-
An Overview of the Heparin-Induced Thrombocytopenia Syndrome Academic Article
-
Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia Academic Article
-
Antibody-mediated platelet activation. Academic Article
-
Antiplatelet Agents in Acute Coronary Syndromes Academic Article
-
Antiplatelet Drugs Academic Article
-
Antiplatelet Effect of Active Components Derived from Chinese Herbal Medicine Academic Article
-
Atorvastatin Delays Murine Platelet Activation In Vivo Even in the Absence of Endothelial NO Synthase Academic Article
-
Autoimmune HIT due to apheresis catheter heparin flushes for stem cell harvesting before autotransplantation for myeloma Conference Paper
-
Autoimmune heparin‐induced thrombocytopenia Academic Article
-
BF061, a novel antiplatelet and antithrombotic agent targeting P2Y12 receptor and phosphodiesterase Academic Article
-
Binding of Thrombin to the G-protein-linked Receptor, and Not to Glycoprotein Ib, Precedes Thrombin-mediated Platelet Activation Academic Article
-
Cardiovascular Devices and Platelet Interactions Academic Article
-
Clinical picture of heparin-induced thrombocytopenia (HIT) and its differentiation from non-HIT thrombocytopenia Academic Article
-
Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes Academic Article
-
Clopidogrel in acute coronary syndromes: Where are we now? Academic Article
-
Cold‐stored leukoreduced whole blood: Extending the time between donation and filtration has minimal impact on in vitro quality Academic Article
-
Combination of two complementary automated rapid assays for diagnosis of heparin‐induced thrombocytopenia (HIT) Academic Article
-
Comparison of the Proinflammatory and Procoagulant Properties of Nuclear, Mitochondrial, and Bacterial DNA Academic Article
-
Coordinate Activation of Human Platelet Protease-activated Receptor-1 and -4 in Response to Subnanomolar α-Thrombin Academic Article
-
Covalently linking heparin to antithrombin enhances prothrombinase inhibition on activated platelets Academic Article
-
Dark Chocolate Effect on Platelet Activity, C-Reactive Protein and Lipid Profile: A Pilot Study Academic Article
-
Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis Academic Article
-
Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia. Academic Article
-
Development of a high-yield expression and purification system for platelet factor 4 Academic Article
-
Diagnosis of suspected inherited platelet function disorders: results of a worldwide survey Academic Article
-
Diannexin, an annexin A5 homodimer, binds phosphatidylserine with high affinity and is a potent inhibitor of platelet‐mediated events during thrombus formation Academic Article
-
Distinguishing between anti–platelet factor 4/heparin antibodies that can and cannot cause heparin‐induced thrombocytopenia Academic Article
-
Dual Pathway Inhibition for Vascular Protection in Patients with Atherosclerotic Disease: Rationale and Review of the Evidence Academic Article
-
Early‐onset and persisting thrombocytopenia in post‐cardiac surgery patients is rarely due to heparin‐induced thrombocytopenia, even when antibody tests are positive Academic Article
-
Effect of Atrial Fibrillation on Atrial Thrombogenesis in Humans: Impact of Rate and Rhythm Academic Article
-
Effect of C4-, C8- and C18- alkylation of poly(vinyl alcohol) hydrogels on the adsorption of albumin and fibrinogen from buffer and plasma: limited correlation with platelet interactions Academic Article
-
Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparin Academic Article
-
Effect of recombinant factor VIIa on melagatran-induced inhibition of thrombin generation and platelet activation in healthy volunteers Academic Article
-
Effects of ticagrelor versus clopidogrel on platelet function in fibrinolytic-treated STEMI patients undergoing early PCI Academic Article
-
Endothelial and Platelet Activation in Acute Ischemic Stroke and Its Etiological Subtypes Academic Article
-
Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial Academic Article
-
Factor V Is Complexed with Multimerin in Resting Platelet Lysates and Colocalizes with Multimerin in Platelet α-Granules Academic Article
-
Failure of Aspirin to Prevent Atherothrombosis Academic Article
-
FcγRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia Academic Article
-
Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT Academic Article
-
Formation of anti–platelet factor 4/heparin antibodies after cardiac surgery: Influence of perioperative platelet activation, the inflammatory response, and histocompatibility leukocyte antigen status Academic Article
-
Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2 Academic Article
-
HIT complicating fondaparinux prophylaxis: fondaparinux-dependent platelet activation as a marker for fondaparinux- induced HIT Academic Article
-
HIT paradigms and paradoxes Academic Article
-
HITlights: A career perspective on heparin-induced thrombocytopenia Academic Article
-
HUMAN PLATELET THROMBIN RECEPTORS Academic Article
-
Haemolytic uraemic syndrome is an immune-mediated disease: role of anti-CD36 antibodies Academic Article
-
Heparin and Platelets Academic Article
-
Heparin-Induced Thrombocytopenia Academic Article
-
Heparin-Induced Thrombocytopenia Academic Article
-
Heparin-Induced Thrombocytopenia Associated with Fondaparinux Academic Article
-
Heparin-Induced Thrombocytopenia: A Clinicopathologic Syndrome Academic Article
-
Heparin-Induced Thrombocytopenia: A Ten-Year Retrospective Academic Article
-
Heparin-Induced thrombocytopenia: IgG-Mediated platelet activation, platelet microparticle generation, and altered procoagulant/anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-Induced thrombocytopenia Academic Article
-
Heparin-induced thrombocytopenia: A stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings Academic Article
-
Heparin-induced thrombocytopenia: a historical perspective Academic Article
-
Heparin-induced thrombocytopenia: pathogenesis and management Academic Article
-
Heparin‐induced skin lesions Academic Article
-
Heparin‐induced thrombocytopenia – therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4–heparin complexes Academic Article
-
Heparin‐induced thrombocytopenia: a prospective study on the incidence, platelet‐activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes Academic Article
-
High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review Academic Article
-
High‐dose intravenous immunoglobulin to treat spontaneous heparin‐induced thrombocytopenia syndrome Academic Article
-
How I Diagnose and Manage HIT Academic Article
-
How I treat patients with a history of heparin-induced thrombocytopenia Academic Article
-
Immune heparin-induced thrombocytopenia can occur in patients receiving clopidogrel and aspirin Academic Article
-
In vitro evaluation of prestorage pooled leukoreduced whole blood-derived platelets stored for up to 7 days Academic Article
-
Influenza virus H1N1 activates platelets through FcγRIIA signaling and thrombin generation Academic Article
-
Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia Academic Article
-
Intensified antiplatelet therapy in patients after percutaneous coronary intervention with high on‐treatment platelet reactivity: the OPTImal Management of Antithrombotic Agents (OPTIMA)‐2 Trial Academic Article
-
Intravenous Immune Globulin to Prevent Heparin-Induced Thrombocytopenia Academic Article
-
Investigation of the mechanisms of monoclonal antibody-induced platelet activation Academic Article
-
Laboratory diagnosis of heparin‐induced thrombocytopenia Academic Article
-
Laboratory testing for heparin-induced thrombocytopenia. Academic Article
-
Lessons from vaccine-induced immune thrombotic thrombocytopenia Academic Article
-
Management of heparin-induced thrombocytopenia Academic Article
-
Measurement of fibrinogen binding to platelets in whole blood by flow cytometry: a micromethod for the detection of platelet activation Academic Article
-
Measurement of soluble P‐selectin and soluble CD40 ligand in serum and plasma Academic Article
-
Morphological analysis of microparticle generation in heparin-induced thrombocytopenia Academic Article
-
Multicentre evaluation of 5B9, a monoclonal anti‐PF4/heparin IgG mimicking human HIT antibodies, as an internal quality control in HIT functional assays: Communication from the ISTH SSC Subcommittee on Platelet Immunology Academic Article
-
Multimerin 1 Academic Article
-
New Approaches to the Diagnosis of Heparin-Induced Thrombocytopenia Academic Article
-
Nonheparin Anticoagulants for Heparin-Induced Thrombocytopenia Academic Article
-
PF4‐dependent immunoassays and inferential detection of HIT antibodies Academic Article
-
Panax notoginseng saponin is superior to aspirin in inhibiting platelet adhesion to injured endothelial cells through COX pathway in vitro Academic Article
-
Plasma exchange to remove HIT antibodies: dissociation between enzyme-immunoassay and platelet activation test reactivities Academic Article
-
Plasmin accelerates platelet‐dependent prothrombinase formation without activating the platelets Academic Article
-
Platelet Accumulation on Fibrin-coated Polyethylene: Role of Platelet Activation and Factor XIII \textbar Request PDF Academic Article
-
Platelet Activation Testing for Heparin-Induced Thrombocytopenia Antibodies Academic Article
-
Platelet activation and hypercoagulability following treatment with porcine factor VIII (HYATE:C) Academic Article
-
Platelet activation induced by porcine factor VIII (HYATE:C) Academic Article
-
Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay Academic Article
-
Platelet-leukocyte aggregation under shear stress: Differential involvement of selectins and integrins Academic Article
-
Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration Academic Article
-
Prevalence and clinical implications of anti-PF4/heparin antibodies in intensive care patients: a prospective observational study Academic Article
-
Prognostic significance of platelet and microvessel counts in operable non-small cell lung cancer Academic Article
-
Prolonged Expression of Procoagulant Activity of Human Platelets Degranulated by Thrombin Academic Article
-
Protamine (heparin)‐induced thrombocytopenia: a review of the serological and clinical features associated with anti‐protamine/heparin antibodies Academic Article
-
Protease activated receptors 1 and 4 govern the responses of human platelets to thrombin Academic Article
-
Prothrombotic Effects of Hyperhomocysteinemia and Hypercholesterolemia in ApoE-Deficient Mice Academic Article
-
Quantitative interpretation of optical density measurements using PF4‐dependent enzyme‐immunoassays Academic Article
-
Rabbit lung macrophages stimulate platelets in vitro as observed by density-gradient centrifugation and transmission electron microscopy Article
-
Reasons for resistance to aspirin in cardiovascular disease. Academic Article
-
Rivaroxaban plus aspirin for cardiovascular protection: Rationale for the vascular dose and dual pathway inhibition Academic Article
-
Rivaroxaban with or without aspirin for prevention of cardiovascular disease Academic Article
-
Role of Secreted Adenosine Diphosphate in the Synergistic Effects of Cathepsin G on Human Platelets Academic Article
-
SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopenia Academic Article
-
Serotonin‐release assay‐positive but platelet factor 4‐dependent enzyme‐immunoassay negative: HIT or not HIT? Academic Article
-
Serum-induced platelet procoagulant activity: An assay for the characterization of prothrombotic disorders Academic Article
-
Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention Academic Article
-
Site of Action for the Inhibition by Gold Sodium Thiomalate of Rabbit Platelet Activation Academic Article
-
Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction. Academic Article
-
The COVID Complex: A Review of Platelet Activation and Immune Complexes in COVID-19 Academic Article
-
The Effects of Steroids on Coagulation Dysfunction Induced by Cardiopulmonary Bypass: A Steroids in Cardiac Surgery (SIRS) Trial Substudy Academic Article
-
The association between platelet activation and FcγRIIa proteolysis Academic Article
-
The functions of the A1A2A3 domains in von Willebrand factor include multimerin 1 binding Academic Article
-
The mechanism of action of thrombin inhibitors. Academic Article
-
The role of fluid-phase immune complexes in the pathogenesis of heparin-induced thrombocytopenia Academic Article
-
The role of microRNAs in prethrombotic status associated with coronary artery disease Academic Article
-
The role of platelets and platelet inhibition in acute myocardial infarction Academic Article
-
Thrombin binding to platelets and their activation in plasma Academic Article
-
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination Academic Article
-
Thrombus formation: direct real-time observation and digital analysis of thrombus assembly in a living mouse by confocal and widefield intravital microscopy Academic Article
-
Update on platelet procoagulant mechanisms in health and in bleeding disorders Academic Article
-
Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation Academic Article
-
p-155, a multimeric platelet protein that is expressed on activated platelets. Academic Article